Auro Peptides Ltd
HighSangareddy (near Hyderabad), India
GMP
Peptide API subsidiary of Aurobindo Pharma with a plant near Hyderabad. Makes generic peptide APIs and runs GMP contract projects from mg to kg scale.
- Model
- CDMO
- Manufacturer?
- Yes
Peptide Manufacturers in India
17 companies are listed as peptide manufacturers and suppliers in India. 16 hold active US Drug Master Files for peptide APIs, most often for Semaglutide, Icatibant, Liraglutide. 14 have a regulator record of GMP manufacturing. 12 score High (90 or more). 3 listings carry an open FDA warning letter, which caps the score at 60.
Ordered by score. Scores follow the published rules and are not affected by paid placement. Updated 2026-11-13.
Peptide CDMOs (8)
Gland Pharma Ltd
HighHyderabad, India
GMP
Hyderabad injectables CDMO founded 1978, promoted by Fosun Pharma; FDA-inspected sites; US DMF for glatiramer acetate.
- Model
- CDMO
- Manufacturer?
- Yes
MSN Life Sciences Private Ltd (MSN Group)
HighHyderabad, India
GMP
Hyderabad-based MSN Group entity holding US DMFs for 11 peptide APIs, including semaglutide and tirzepatide. MSN runs 27 plants in India, the USA and Indonesia.
- Model
- CDMO
- Manufacturer?
- Yes
Piramal Pharma Ltd (Piramal Pharma Solutions)
HighNavi Mumbai, India
GMP
Indian CDMO whose Turbhe, Navi Mumbai site develops and makes peptide APIs by solid- and solution-phase synthesis. Holds US DMFs for 9 peptide APIs.
- Model
- CDMO
- Manufacturer?
- Yes
Shilpa Pharma Lifesciences Ltd
HighRaichur, India
GMP
Raichur API and CDMO subsidiary of Shilpa Medicare; US DMFs for desmopressin, liraglutide and octreotide; Raichur units inspected by US FDA in 2025.
- Model
- CDMO
- Manufacturer?
- Yes
Neuland Laboratories
HighHyderabad, India
GMPCOA
Indian API manufacturer and CDMO with a peptide synthesis platform.
- Model
- CDMO
- Manufacturer?
- Yes
Hemmo Pharmaceuticals Pvt Ltd (Piramal Pharma Solutions)
HighNavi Mumbai, India
GMP
Mumbai peptide API maker acquired by Piramal Pharma in 2021; its oxytocin API is WHO-prequalified; US DMF for oxytocin.
- Model
- CDMO
- Manufacturer?
- Yes
Sai Life Sciences Ltd
HighHyderabad, India
Indian contract research, development and manufacturing organization (CRDMO) listed on NSE and BSE. It has opened a dedicated Peptide Research Center in Hyderabad.
- Model
- CDMO
- Manufacturer?
- Yes
Peptide API and research peptide manufacturers (9)
Alembic Pharmaceuticals Ltd
HighVadodara, India
GMP
Vadodara drug maker, dating to 1907, with three API plants and six formulation plants. Holds US DMFs for 6 peptide APIs, including glatiramer and tirzepatide.
- Model
- Manufacturer
- Manufacturer?
- Yes
Biocon Ltd
HighBengaluru, India
GMP
Bengaluru biopharma company that makes generic APIs and complex formulations, including GLP-1 peptides. Holds US DMFs for liraglutide, semaglutide and tirzepatide.
- Model
- Manufacturer
- Manufacturer?
- Yes
FDC Limited
HighMumbai, India
GMP
Mumbai drugmaker founded in 1936 with six plants, including a US-FDA-accredited API site at Roha; holds an active US DMF for semaglutide.
- Model
- Manufacturer
- Manufacturer?
- Yes
Biophore India Pharmaceuticals Pvt Ltd
HighHyderabad, India
GMP
Hyderabad API developer and maker founded in 2007, focused on niche and complex products. Holds US DMFs for cetrorelix, icatibant and sincalide.
- Model
- Manufacturer
- Manufacturer?
- Yes
Hetero Drugs Ltd
MediumHyderabad, India
Privately held Hyderabad generics and API group with 36+ plants; US DMFs for semaglutide and vasopressin.
- Model
- Manufacturer
- Manufacturer?
- Yes
Reliance Life Sciences Pvt Ltd
MediumNavi Mumbai, India
Navi Mumbai biopharma and specialty pharma company; US DMFs for lanreotide and liraglutide.
- Model
- Manufacturer
- Manufacturer?
- Yes
Cipla Ltd
LowMumbai, India
GMP
Mumbai drug maker incorporated in 1935 with plants in India and the USA. Holds US DMFs for difelikefalin, icatibant and terlipressin. Pithampur FDA warning letter still open.
Notice: open regulatory issue
- Model
- Manufacturer
- Manufacturer?
- Yes
Sun Pharmaceutical Industries Ltd
LowMumbai, India
GMP
Mumbai-based generics group that makes APIs and finished medicines. Holds US Type II DMFs for 15 peptide APIs, including GLP-1s and GnRH analogues.
Notice: open regulatory issue
- Model
- Manufacturer
- Manufacturer?
- Yes
USV Private Limited
LowMumbai, India
GMP
Mumbai drug maker with its own API and formulation plants in India. Holds US DMFs for 3 peptide APIs. Received an FDA CGMP warning letter in November 2026.
Notice: open regulatory issue
- Model
- Manufacturer
- Manufacturer?
- Yes
More in India
Peptide APIs with US DMFs held by companies in India
- Semaglutide (8)
- Icatibant (7)
- Liraglutide (7)
- Octreotide (7)
- Leuprolide (5)
- Bortezomib (4)
- Cetrorelix (4)
- Desmopressin (4)
- Lanreotide (4)
- Teriparatide (4)
- Vasopressin (4)
- Caspofungin (3)
Peptide Manufacturers in other countries
Frequently asked questions
How many peptide manufacturers and suppliers in India are listed?
17 companies. Each listing shows location, business model, documentation and a score from 0 to 100.
Which peptide manufacturers and suppliers in India score highest?
By score: Alembic Pharmaceuticals Ltd (98), Auro Peptides Ltd (98), Biocon Ltd (98), FDC Limited (98), Gland Pharma Ltd (98). Scores measure checkable evidence, not product quality, and paid placement does not change them.
Which peptide manufacturers and suppliers in India hold US Drug Master Files?
Alembic Pharmaceuticals Ltd, Auro Peptides Ltd, Biocon Ltd, FDC Limited, Gland Pharma Ltd, MSN Life Sciences Private Ltd (MSN Group), Piramal Pharma Ltd (Piramal Pharma Solutions), Shilpa Pharma Lifesciences Ltd, Neuland Laboratories, Biophore India Pharmaceuticals Pvt Ltd and 6 more hold active Type II DMFs for peptide APIs in FDA's DMF list. A DMF is a confidential file submitted to FDA; FDA does not approve DMFs, but drug applications can reference them.
How should I check a supplier before ordering?
Confirm the legal entity, ask for lot-specific certificates of analysis that the testing lab can verify, check FDA warning letters and import alerts, and for GMP material ask for regulator inspection records rather than marketing claims.